HF 4493 Minnesota House · 2025-2026 Regular Session

Pharmacists authorized to initiate, prescribe, administer, and dispense drugs for the treatment of opioid use disorder; and grounds for disciplinary action for pharmacists and pharmacist interns modified.

This bill expands the scope of practice for pharmacists in Minnesota by authorizing them to initiate, prescribe, administer, and dispense medications for treating opioid use disorder. It directly affects licensed pharmacists and pharmacist interns, allowing them to work under protocols or collaborative agreements with other healthcare providers to manage opioid use disorder treatment. The legislation also updates the legal definition of "practitioner" to include pharmacists authorized to prescribe certain medications and modifies disciplinary grounds for pharmacists and interns. These changes aim to increase access to opioid use disorder treatment through pharmacies while maintaining oversight through established healthcare partnerships.
Bill status passed 3 of 5 stages cleared
Introduction
Mar 2026
Committee Review
Apr 2026
House Passage
Apr 2026
Senate Passage
Governor
Introduced Mar 18, 2026 Last action Apr 28, 2026
Floor votes · House Apr 27, 2026

How they voted

1330
Passed
Total votes 133
Apr 27, 2026
D Democratic66
66 Yea
100% Yea
R Republican67
67 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
10
Key actions
2
Committee
2
Apr 28, 2026
Committee
Referred to Health and Human Services
upper
Apr 28, 2026
Introduced
Introduction and first reading
upper
Apr 28, 2026
Introduced
Received from House
upper
Apr 27, 2026
Lower · Passed
Bill was passed
lower
Apr 7, 2026
Lower · Passed
Committee report, to adopt
lower
Mar 18, 2026
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 2 co-sponsors

Sponsors